HumeCare+ vs Hers: Compounded Protocols vs FDA-Approved Wegovy
HumeCare+ vs Hers comes down to protocol design and product type: HumeCare+ bundles physician-prescribed compounded semaglutide or tirzepatide with glycine and B vitamins and body-composition scans, starting at $199/mo for semaglutide, while Hers emphasizes FDA-approved Wegovy and other brand-name GLP-1 options from $149/mo with a membership requirement. Early verdict: choose HumeCare+ if you want bundled muscle-preserving supports and scans with a money-back promise; choose Hers if you prefer FDA-approved brand-name medication and a standard prescription pathway.
Explore HumeCare+ protocol and pricing
Direct comparison: medication type and regulatory status
HumeCare+ sells compounded GLP-1 medications dispensed from U.S. pharmacies and notes that compounded medications are not evaluated by the FDA for safety, quality, or efficacy. Hers sells FDA-approved brand-name Wegovy and other name-brand GLP-1s, explicitly stating Wegovy is FDA-approved and not compounded. This is a central difference: HumeCare+ offers compounded semaglutide from $199/mo and a tirzepatide protocol from $299/mo, while Hers lists Wegovy pill options from $149/mo and injectable options from $199/mo, with brand-name availability subject to clinical eligibility.
Distinctive difference 1: bundled supportive protocol vs name-brand medication
HumeCare+ packages personalized compounded semaglutide or tirzepatide with glycine, vitamin B12 and B6 built into the formulation, plus an app and monthly body-composition scans. HumeCare+ positions these additions as muscle-preserving and aimed at side-effect relief. Hers focuses on FDA-approved Wegovy and a personalized care team with ongoing dose check-ins, but does not offer compounded or built-in supportive ingredients.
See HumeCare+ protocol details
Distinctive difference 2: tracking and clinician access
HumeCare+ offers monthly body-composition scans that the company says track lean mass versus fat over time and provides unlimited clinician access and a U.S. care team available 24/7. Hers offers a personalized care team with ongoing dose check-ins but the source evidence does not describe monthly body-composition scans or 24/7 unlimited clinician access. Both require a clinician to determine medical appropriateness before treatment.
Distinctive difference 3: pricing structure and membership
HumeCare+ lists semaglutide from $199/mo and tirzepatide protocol from $299/mo; its pricing is cash-pay and the listing reflects a promotional discount that may change. Hers advertises name-brand Wegovy from $149/mo for the pill and from $199/mo for injectables, but an active Hers Weight Loss Membership is required: $39 for the first month, auto-renews at $149/month thereafter, and medication is billed separately if prescribed. The Hers evidence also notes medication availability and total cost depend on prescription, eligibility and state availability and that medication is not available without an active membership.
Check Hers membership and Wegovy pricing
Comparison table: key criteria
| Criteria | HumeCare+ | Hers |
|---|---|---|
| Medication type | Compounded semaglutide or tirzepatide | FDA-approved Wegovy and other brand-name GLP-1s |
| Starting price | Semaglutide from $199/mo; tirzepatide from $299/mo | Wegovy pill from $149/mo; injectables from $199/mo |
| Supportive ingredients | Glycine plus vitamins B6 and B12 built into formulation | No compounded supportive ingredients offered |
| Tracking | Monthly body-composition scans tracking lean mass | Personalized care team and dose check-ins; scans not described |
| Clinician access | Unlimited clinician access; U.S. care team 24/7 | Personalized care team with ongoing dose check-ins |
| Money-back promise | 10%-or-your-money-back promise over six months, terms apply | No money-back promise provided in source evidence |
Safety, regulatory and availability notes
HumeCare+ warns that compounded medications are not FDA-evaluated for safety, quality, or efficacy. Hers emphasizes FDA-approved brand-name Wegovy and notes some GLP-1s are FDA-approved for weight loss while others are approved for diabetes and may be prescribed off-label. Hers also notes not all medications are available in all 50 states and prescription is required. Both providers state treatment is available only when a licensed clinician determines it is medically appropriate.
Other product claims and evidence limits
HumeCare+ cites internal, company-reported figures and a money-back promise tied to a 10% weight-loss threshold; the source cautions to verify full terms and eligibility. Hers lists name-brand outcomes examples but the captured evidence does not expand membership eligibility details beyond the stated fees. No external guarantees of clinical outcomes are supplied in the source evidence.
Join HumeCare+ to review eligibility and scans
Start Hers enrollment and eligibility check
Conclusion: how to choose between HumeCare+ vs Hers
Choose HumeCare+ if you want a bundled protocol that pairs compounded semaglutide or tirzepatide with glycine and B vitamins, monthly body-composition scans, unlimited clinician access and a 10%-or-your-money-back promise over six months. Choose Hers if you prefer FDA-approved, brand-name Wegovy and other name-brand GLP-1s, a personalized care team with ongoing dose check-ins, and a membership-based ordering model with separate medication billing and state and eligibility limits.